Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Hemagglutinin of influenza A virus antagonizes type I IFN responses by inducing degradation of type I IFN receptor 1.

J Virol.. 2015-12; 
Xia C, Vijayan M, Pritzl CJ, Fuchs SY, McDermott AB, Hahm B.
Products/Services Used Details Operation
Catalog Antibody ... Cycloheximide (CHX, Sigma-Aldrich), which was used to block protein synthesis, Anti- 134 DYKDDDDK (FLAG) G1 Affinity Resin (GenScript), protease inhibitor PMSF (Gold Bio), 135 immunoprecipitation (IP) lysis buffer (Thermo Scientific), proteasome inhibitor MG132 136 ... Get A Quote

摘要

Influenza A virus (IAV) employs diverse strategies to circumvent type I interferon (IFN) responses, particularly by inhibiting the synthesis of type I IFNs. However, it is poorly understood if and how IAV regulates the type I IFN receptor (IFNAR)-mediated signaling mode. In this study, we demonstrate that IAV induces the degradation of IFNAR subunit 1 (IFNAR1) to attenuate the type I IFN-induced antiviral signaling pathway. Following infection, the level of IFNAR1 protein, but not mRNA, decreased. Indeed, IFNAR1 was phosphorylated and ubiquitinated by IAV infection, which resulted in IFNAR1 elimination. The transiently overexpressed IFNAR1 displayed antiviral activity by inhibiting virus replication. Importantl... More

关键词

XML 地图